Frontlight ResearchEarly access
Macular degeneration trials in Egypt
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleEvaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
- Where
- Cairo, Giza
- People
- 100
- Run by
- Ace Cells Lab Limited
See details and how to joinNCT06787482